Terapinis centras aš pats - Company finances
|
EUR
|
2023
From: 2023-01-11
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 22,413 | 43,683 | 38,755 |
| Profit before tax | - | - | 273 |
| Net profit | 4,533 | 11,413 | 255 |
| Equity | 4,633 | 16,047 | 10,734 |
| Liabilities | 1,467 | 4,436 | 5,007 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 6,159 | 20,487 | 15,459 |
| Total assets | 6,159 | 20,487 | 15,459 |
|
Taxes paid
|
|||
| STI taxes | 2,174 | 4,320 | 7,223 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +94.9% | -11.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 73.6% | 55.7% | 1.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 97.8% | 71.1% | 2.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 20.2% | 26.1% | 0.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 43,683 | 38,755 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Terapinis centras aš pats - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-09-03 | 2024-09-30 | 0.33 |
| 2024-08-01 | 2024-08-31 | 0.33 |
| 2023-07-19 | 2023-07-31 | 170.44 |
Terapinis centras aš pats - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
aš pats, UAB (code 306215240) is a Private Limited Liability Company active in other human health activities n.e.c. In 2025, the latest financial year, the company generated revenue of €38.8K, down 11.3% year on year, while net profit fell to €255 and the profit margin narrowed to 0.7%. Over the longer term, revenue still shows growth: it increased from €22.4K in 2023 to €43.7K in 2024, before easing in 2025, which leaves the two-year change at +72.9%. Profitability followed a similar pattern, with net profit of €4.5K in 2023 and €11.4K in 2024, then a much lower result in 2025. At the end of 2025, total assets stood at €15.5K, equity at €10.7K and liabilities at €5.0K. Key ratios indicate a solid balance sheet structure, with an equity ratio of 69.4%, debt-to-equity of 0.47, ROE of 2.4%, ROA of 1.6% and asset turnover of 2.51x. Revenue per employee was €38.8K, while profit per employee was €255.